Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


25.06.2018

4 Blood
1 Br J Haematol
1 Eur J Haematol
1 Haematologica
3 Leuk Lymphoma
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. SVOBODA J, Rheingold SR, Gill SI, Grupp SA, et al
    Non-viral RNA chimeric antigen receptor modified T cells in patients with Hodgkin lymphoma.
    Blood. 2018 Jun 20. pii: blood-2018-03-837609. doi: 10.1182/blood-2018-03-837609
    PubMed     Text format     Abstract available

  2. OISHI N, Brody GS, Ketterling RP, Viswanatha DS, et al
    Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.
    Blood. 2018 Jun 19. pii: blood-2017-12-821868. doi: 10.1182/blood-2017-12-821868
    PubMed     Text format    

  3. KALPADAKIS C, Pangalis GA, Sachanas S, Tsirkinidis P, et al
    Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.
    Blood. 2018 Jun 18. pii: blood-2018-02-833608. doi: 10.1182/blood-2018-02-833608
    PubMed     Text format    

  4. CHOW VA, Shadman M, Gopal AK
    Translating anti-CD19 CAR T-Cell therapy into clinical practice for relapsed/refractory diffuse large B-Cell lymphoma.
    Blood. 2018 Jun 18. pii: blood-2018-04-839217. doi: 10.1182/blood-2018-04-839217
    PubMed     Text format     Abstract available


    Br J Haematol

  5. DERENZINI E, Agostinelli C, Rossi A, Rossi M, et al
    Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.
    Br J Haematol. 2018 Jun 17. doi: 10.1111/bjh.15442.
    PubMed     Text format    


    Eur J Haematol

  6. SU YJ, Wang PN, Chang H, Shih LY, et al
    Extranodal NK/T Cell Lymphoma, Nasal Type: Clinical Features, Outcome and Prognostic Factors in 101 Cases.
    Eur J Haematol. 2018 Jun 16. doi: 10.1111/ejh.13126.
    PubMed     Text format     Abstract available


    Haematologica

  7. MCPHAIL ED, Maurer MJ, Macon WR, Feldman AL, et al
    Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.
    Haematologica. 2018 Jun 14. pii: haematol.2018.190157.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  8. AGARWAL R, Dawson MA, Dreyling M, Tam CS, et al
    Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials.
    Leuk Lymphoma. 2018 Jun 18:1-13. doi: 10.1080/10428194.2018.1457148.
    PubMed     Text format     Abstract available

  9. CALZADA O, Switchenko JM, Maly JJ, Blum KA, et al
    Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma.
    Leuk Lymphoma. 2018 Jun 18:1-9. doi: 10.1080/10428194.2018.1455973.
    PubMed     Text format     Abstract available

  10. HONG H, Fang X, Wang Z, Huang H, et al
    Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
    Leuk Lymphoma. 2018 Jun 18:1-6. doi: 10.1080/10428194.2018.1459610.
    PubMed     Text format     Abstract available


    PLoS One

  11. GAO X, Li J, Wang Y, Liu S, et al
    Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2018;13:e0199398.
    PubMed     Text format     Abstract available

  12. MORENO MJ, Gallardo A, Novelli S, Mozos A, et al
    CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
    PLoS One. 2018;13:e0198789.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: